Celanese (CE) traded higher in the April 16, 2026 session, building on momentum from a cluster of recent analyst actions that lifted price targets and refreshed the near-term narrative around a second-half 2026 recovery. Traders appear to be positioning for improving end-market demand and operating leverage after a weak start to the year, keeping the stock bid even on a modest up-day.

In the last week, RBC raised its price target to $66 (kept Sector Perform), reinforcing the view that expectations have stabilized versus prior cautious setups. Wells Fargo also recently raised its price target to $75, providing a clear reference point for bulls focused on a second-half recovery setup; more broadly, the stock has been sensitive to incremental changes in sell-side outlook and targets as the market debates the pace of demand normalization.

Celanese remains in a transition period where confidence in the timing of volume recovery and balance-sheet progress can move the stock quickly. The market is effectively treating the name as a macro-plus-execution story: if demand and pricing hold while deleveraging advances, upgrades and target lifts can trigger outsized day moves; if the recovery slips, the stock can give back gains just as fast.